|
| |
| | | 66435 | | 03.07.2018 | | Sandoz Pharmaceuticals AG | | | | | | | | | | | | | 07.16.10. | | | | 07.16.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Rixathon 100 mg/10 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Rituximab 100mg / 10ml) | L01FA01 | | | 02 | Rixathon 500 mg/50 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Rituximab 500mg / 50ml) | L01FA01 | |
|
|
|
